Related Experiment Videos
Clinical study of cefpimizole in obstetric and gynecologic infections
The Japanese Journal of Antibiotics
|April 1, 1985
Abstract:
The use of cefpimizole (AC-1370) in 11 patients with a variety of obstetric and gynecologic infections was studied. Although the activity of AC-1370 was found in vitro less eminent than those of currently employed antibiotic regimens, the overall clinical response was 82%. No side effects were found.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Diffusion-weighted imaging of pancreatic cancer at 3 tesla: Practical comparison of readout-segmented and single-shot echo-planar imaging for image quality.
Radiography (London, England : 1995)·2026
The effect of laminin-1 on enteric neural crest-derived cell migration in the Hirschsprung's disease mouse model.
Pediatric surgery international·2017
Droplet digital PCR measurement of HER2 in patients with gastric cancer.
British journal of cancer·2015
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.
British journal of cancer·2013
Evaluation of rapid measurement of Chlamydia trachomatis and Neisseria gonorrhoeae by using automatic gene analyzer "GENECUBE".
The Japanese journal of antibiotics·2018
Clinical analysis of the pediatric inpatients with lower respiratory tract infection due to human metapneumovirus.
The Japanese journal of antibiotics·2018
Visual disturbance or central symptom like hallucination in patients treated voriconazole: report of six cases.
The Japanese journal of antibiotics·2018
Therapeutic Effects of Matricaria chamomilla Extract in an Immunosuppressed Mouse Model of Cryptosporidiosis.
Veterinary medicine and science·2026
[Biomechanical effect of acupotomy on cartilage degeneration in rabbits with knee osteoarthritis].
Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026
Overcoming cordycepin limitations with SLNs-based nanoformulation: formulation development and cytotoxicity evaluation against human breast cancer cells.
Medical oncology (Northwood, London, England)·2026